Deadline: 24-Mar-23
The Centers for Disease Control (CDC) is pleased to announce the applications to Sustain and Accelerate a Comprehensive HIV Response in the United Republic of Tanzania under the President’s Emergency Plan for AIDS Relief (PEPFAR).
This NOFO supports the Government of Tanzania (GOT) strategy for comprehensive HIV prevention and treatment and systems strengthening interventions addressing the entire continuum of care. Recipient(s) is expected to implement innovative, evidence-based, person-centered, and culturally appropriate interventions to enhance identification of HIV-positive individuals; linkage to Care and Treatment Clinics (CTC) for same day initiation antiretroviral therapy (ART); support for community-based HIV services; access to HIV services for priority populations; continuity of treatment and patient adherence to ART, monitoring of viral load (VL) to attain viral suppression; and utilization of appropriate data for continuous quality improvement (CQI).
The targeted populations include children, adolescent boys, men, adolescent girls and young women (AGYW), pregnant women, breastfeeding mothers and infants, key and vulnerable populations (KVP), and at-risk groups. Activities are expected to be carried out in Dar es Salaam, Kagera, Mara, Simiyu, Tanga, and Zanzibar. This may shift to other CDC-supported regions based on performance or epidemiologic data. Recipient(s) may be awarded comprehensive community and facility-based activities for specific region(s).
Goals and Priorities
- Reducing the prevention and treatment gaps for adolescent girls and young women (AGYW), children, and key populations (KP);
- Strengthening national and local programmatic, financial, and community leadership;
- Designing new partnerships with key private, public, and multi sector entities that can complement existing programs and expand reach;
- Utilizing the PEPFAR platform for broader disease surveillance and public health programming, consistent with the PEPFAR legislative and funding authority;
- Investing in the scale-up of cutting edge behavioral, and implementation science to bend the curve on new infections;
- Improving the care and treatment of HIV/AIDS, sexually transmitted infections (STIs), and related opportunistic infections by improving STI management; enhancing laboratory diagnostic capacity and the care and treatment of opportunistic infections; interventions for intercurrent diseases impacting HIV infected patients including tuberculosis (TB); and initiating programs to provide anti-retroviral therapy (ART);
- Strengthening the capacity of countries to collect, use, and share surveillance data and manage national HIV/AIDS programs by expanding HIV/STI/TB surveillance programs and strengthening laboratory support for surveillance, diagnosis, treatment, disease monitoring, and HIV screening for blood safety; and
- Developing, validating, and/or evaluating public health programs to inform, improve, and target appropriate interventions, as related to the prevention, care and treatment of HIV/AIDS, TB, and opportunistic infections.
Funding Information
- The expected number of awards is 1-2.
- Average One Year Award Amount: $50,000,000
Eligibility Criteria
Government Organizations:
- State governments or their bona fide agents (includes the District of Columbia)
- Local governments or their bona fide agents
- Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau
- State controlled institutions of higher education
- American Indian or Alaska Native tribal governments (federally recognized or state-recognized)
- Non-government Organizations
- American Indian or Alaska native tribally designated organizations
- Other
- Ministries of Health
For more information, visit Grants.gov.
